
Iyi mfashanyigisho yuzuye itanga ibitaro nurutonde rurambuye rwa impyiko kanseri ya kanseri, ikubiyemo ibintu by'ingenzi byo gusuzuma, insimburangingo, sisitemu yo gutanga amanota, n'ibipimo byerekana ibimenyetso. Dushakisha iterambere rigezweho mu gusobanukirwa no gushyira mu byiciro iyi kanseri igoye, guha abahanga mu bumenyi bw'indwara amakuru akenewe mu gusuzuma no gutegura neza. Gusobanukirwa nu impyiko kanseri ya kanseri ni ngombwa mu kwita ku barwayi neza.
Kanseri y'impyiko (RCC) ni ubwoko bwa kanseri y'impyiko, bukomoka kumurongo w'impyiko. Irangwa nubwoko butandukanye bwamateka, buriwese ufite imyitwarire idasanzwe yubuvuzi nibisubizo byubuvuzi. Kwipimisha neza kwa pathologiya nibyingenzi muguhitamo prognoza no kuyobora ingamba zo kuvura.
Ubwoko butandukanye bwa RCC burahari, harimo selile isobanutse RCC (ccRCC), papillary RCC (pRCC), chromophobe RCC (chRCC), nibindi. Buri subtype yerekana imiterere itandukanye ya morphologique mugupima microscopique. Kumenya neza subtype ningirakamaro muguhitamo amasomo yubuvuzi no guhitamo uburyo bwiza bwo kuvura. Ikigo cy'ubushakashatsi cya Kanseri ya Shandong Baofa (https://www.baofahospital.com/) ni ikigo kiyobora mugupima no kuvura kanseri yimpyiko, kabuhariwe mumajyambere agezweho muri impyiko kanseri ya kanseri.
Isuzumabumenyi rya kanseri y'impyiko ikubiyemo microscopique isuzuma birambuye ingero zabonetse binyuze muri biopsy cyangwa nephrectomy. Ibintu by'ingenzi byasuzumwe birimo morphologie selile, ibiranga kirimbuzi, kuba cytoplasmeque ikuraho (muri ccRCC), nuburyo bwo gukura. Ibisobanuro nyabyo bisaba gusobanukirwa byimbitse ibipimo byo gusuzuma kuri buri bwoko bwa RCC.
Sisitemu yo gutanga amanota ya Fuhrman ikoreshwa muburyo bwo gutondekanya RCC ishingiye kubiranga kirimbuzi, itanga ibimenyetso byerekana ubukana bwibibyimba. Ibindi bipimo byerekana ibimenyetso, harimo ibibyimba (stade ya TNM), gutera imitsi, no gutera lymphovasculaire, nabyo ni ingenzi mu gusuzuma gahunda y’umurwayi na gahunda yo kuvura. Isuzuma ryitondewe ryibi bintu ningirakamaro muburyo bwo kuvura bwihariye.
Immunohistochemie (IHC) igira uruhare runini mugutandukanya ubwoko bwa RCC no gusuzuma imvugo ya biomarkers zitandukanye zishobora gutanga amakuru ateganijwe. Tekinike ya molekuline yubuhanga, harimo nuruhererekane rwibisekuruza bizakurikiraho (NGS), irakoreshwa cyane kugirango hamenyekane ihinduka ry’imiterere rishobora kuvurwa no kuvura no gufata ibyemezo byo kuvura. Ubu buhanga buhanitse bunonosora inzira yo gusuzuma impyiko kanseri ya kanseri.
Nubwo hari iterambere ryinshi, imbogamizi ziracyari mu gusuzuma no gushyira mu byiciro RCC, cyane cyane mu gutandukanya insimburangingo zidasanzwe no gucunga ibibazo bitoroshye. Gukomeza ubushakashatsi no guteza imbere ibikoresho nubuhanga bushya bwo gusuzuma bizaba ingenzi mu kunoza ukuri no gukora neza impyiko kanseri ya kanseri.
Ibitaro bigomba gushyiraho uburyo busanzwe bwo gukora (SOPs) bwo gutunganya, gusuzuma, no gutanga raporo kanseri y'impyiko ingero. Izi SOP zigomba guhuza nubuyobozi bwashyizweho nuburyo bwiza kugirango hamenyekane neza kandi neza mugusuzuma kwisuzumisha. Amahugurwa ahoraho no kuvugurura abapologiste n'abakozi ba laboratoire ni ngombwa.
Gucunga neza kanseri y'impyiko bisaba uburyo butandukanye burimo abapologiste, oncologiste, urologiste, na radiologiste. Ubufatanye n’itumanaho muri izi nzobere ni ngombwa mu kunoza ubuvuzi bw’abarwayi no kwemeza ibyemezo bikwiye byo kuvura.
| Ubwoko bwa RCC | Ibiranga | Ingero ziteganijwe |
|---|---|---|
| Kuraho Akagari RCC | Cytoplasme isobanutse, nucleoli igaragara | Birahinduka, akenshi birakaze |
| Papillary RCC | Papillary yubatswe, vasculature yoroshye | Mubisanzwe bitarakaze kurusha ccRCC |
| Chromophobe RCC | Cytoplasme yera, ibiranga kirimbuzi | Ugereranije |
Icyitonderwa: Aya makuru agamije uburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye inama ninzobere mu buzima kubibazo byose byubuzima.